Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Aringer

Showing results (71-80 of 216) with videos related to

Pageof 22
Sort By:
Annals of the Rheumatic Diseases|December 22, 2019
Response to: 'New 2019 SLE EULAR/ACR classification criteria are valid for identifying patients with SLE among patients admitted for pericardial effusion' by Sacre <i>et al</i>Martin Aringer, Karen Costenbader, Thomas Dörner, et al.
Journal of Autoimmunity|June 20, 2022
Advances in SLE classification criteriaMartin Aringer, Karen Costenbader, Thomas Dörner, et al.
Die Ophthalmologie|August 30, 2021
[Systemic lupus erythematosus induced by tumor necrosis fractor inhibitor-A rare side effect of intermediate uveitis treatment]Janine Lenk, Egbert Matthé, Lutz E Pillunat, et al.
Best Practice & Research. Clinical Rheumatology|May 10, 2024
Classification of systemic lupus erythematosus: From the development of classification criteria to a new taxonomy?Martin Aringer, Daniel Toro-Domínguez, Marta E Alarcón-Riquelme
Annals of the Rheumatic Diseases|December 22, 2019
Response to: 'Development and initial validation of diagnostic gene signatures for systemic lupus erythematosus' by Wang <i>et al</i>Martin Aringer, Karen Costenbader, Thomas Dörner, et al.
Rheumatology (Oxford, England)|November 3, 2020
European League Against Rheumatism (EULAR) recommendations and EULAR/American College of Rheumatology criteria-documenting progress in lupusMartin Aringer, Maria G Tektonidou, Dimitrios Boumpas, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 27, 2019
ReplyMartin Aringer, Karen H Costenbader, Thomas Dörner, et al.
Arthritis and Rheumatism|October 12, 2004
Safety and efficacy of tumor necrosis factor alpha blockade in systemic lupus erythematosus: an open-label studyMartin Aringer, Winfried B Graninger, Günter Steiner, et al.
Annals of the Rheumatic Diseases|October 6, 2019
Response to: 'Do the 2019 EULAR/ACR SLE classification criteria close the door on certain groups of SLE patients?' by Chi <i>et al</i>Martin Aringer, Karen H Costenbader, Thomas Dörner, et al.
Annals of the Rheumatic Diseases|December 14, 2019
Response to: 'European League against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus: the laboratory immunologist's point of view' by Infantino <i>et al</i>Martin Aringer, Karen H Costenbader, Thomas Dörner, et al.
Pageof 22

Showing results (71-80 of 216) with videos related to

Sort By:
Pageof 22
Annals of the Rheumatic Diseases|December 22, 2019
Response to: 'New 2019 SLE EULAR/ACR classification criteria are valid for identifying patients with SLE among patients admitted for pericardial effusion' by Sacre <i>et al</i>Martin Aringer, Karen Costenbader, Thomas Dörner, et al.
Journal of Autoimmunity|June 20, 2022
Advances in SLE classification criteriaMartin Aringer, Karen Costenbader, Thomas Dörner, et al.
Die Ophthalmologie|August 30, 2021
[Systemic lupus erythematosus induced by tumor necrosis fractor inhibitor-A rare side effect of intermediate uveitis treatment]Janine Lenk, Egbert Matthé, Lutz E Pillunat, et al.
Best Practice & Research. Clinical Rheumatology|May 10, 2024
Classification of systemic lupus erythematosus: From the development of classification criteria to a new taxonomy?Martin Aringer, Daniel Toro-Domínguez, Marta E Alarcón-Riquelme
Annals of the Rheumatic Diseases|December 22, 2019
Response to: 'Development and initial validation of diagnostic gene signatures for systemic lupus erythematosus' by Wang <i>et al</i>Martin Aringer, Karen Costenbader, Thomas Dörner, et al.
Rheumatology (Oxford, England)|November 3, 2020
European League Against Rheumatism (EULAR) recommendations and EULAR/American College of Rheumatology criteria-documenting progress in lupusMartin Aringer, Maria G Tektonidou, Dimitrios Boumpas, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 27, 2019
ReplyMartin Aringer, Karen H Costenbader, Thomas Dörner, et al.
Arthritis and Rheumatism|October 12, 2004
Safety and efficacy of tumor necrosis factor alpha blockade in systemic lupus erythematosus: an open-label studyMartin Aringer, Winfried B Graninger, Günter Steiner, et al.
Annals of the Rheumatic Diseases|October 6, 2019
Response to: 'Do the 2019 EULAR/ACR SLE classification criteria close the door on certain groups of SLE patients?' by Chi <i>et al</i>Martin Aringer, Karen H Costenbader, Thomas Dörner, et al.
Annals of the Rheumatic Diseases|December 14, 2019
Response to: 'European League against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus: the laboratory immunologist's point of view' by Infantino <i>et al</i>Martin Aringer, Karen H Costenbader, Thomas Dörner, et al.
Pageof 22